Form 4 for A Agilent Technologies
Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-17 · accession 0001127602-22-010051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-03-21 | 2022-03-17 | A | FIELDS HEIDI | Dir | A - Grant | $136.82 | +1,785 | 57.8K | +3% | +$244.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | A | A | 1,785 | $136.82 | 57,849.69 | I Heidi K. Fields Living Trust | — | — | (F1) Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. (F2) 297.073 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock. (F3) Shares held in the Heidi K. Fields Living Trust. |